Segal Trials

The resurgence of interest in psychedelics, once sidelined by regulatory crackdowns and societal skepticism, marks a pivotal turn in the quest for effective mental health treatments. Psychedelic drugs, encompassing substances like psilocybin (found in magic mushrooms), LSD, MDMA (ecstasy), and ayahuasca, have moved from the fringes of scientific inquiry to the forefront of innovative psychiatric research. This article delves into how psychedelics are revolutionizing the treatment of mental illnesses such as anxiety, depression, addiction, and PTSD, the limitations of current pharmaceutical options, and the promising horizon of psychedelic-assisted therapy, underscored by rigorous clinical research aiming for FDA approval.

Exploring treatment-resistant depression (TRD), this article highlights new research and strategies offering hope through understanding risk factors, rethinking depression's causes, and innovative management methods.

The contributions made to our community from caregivers is monumental, and we want to provide resources, information, and the latest news to help support them. Please share this blog with other caregivers, family and friends and be sure to leave us a comment below.

Exploring how the lingering effects of COVID-19 in 2023 further influence depression rates and mental health challenges. 

Postpartum depression (PPD) is a complex mood disorder that affects many new mothers in the weeks and months following childbirth. It’s essential to understand that PPD is more than just "baby blues," a term used to describe the mild, short-term sadness many women feel after giving birth. The symptoms of PPD can range from persistent feelings of sadness, hopelessness, and worthlessness to overwhelming fatigue, severe anxiety, and even thoughts of harming oneself or the baby. Some of the contributing factors include hormonal changes after childbirth, a history of depression or anxiety, childbirth-related trauma, and various stressors associated with new motherhood.

In recent years, the exploration of psychedelics' therapeutic potential has sparked a remarkable revolution in mental health research. With prejudice giving way to evidence-based understanding, scientists are delving deeper into the profound impact psychedelics may have on mental well-being. This blog post examines the significance of psychedelics research in transforming mental health treatment, offering a glimmer of hope to millions worldwide.

Clinical trials are crucial for the development and evaluation of new medical treatments and interventions. A key component of these trials is the use of placebos, which play a critical role in understanding the efficacy and safety of investigational drugs or treatments. In this article, we will research the concept of placebos in clinical trials, explore examples of placebos, discuss the pros and cons of placebo-controlled trials, examine the role of placebos in drug studies, and address the ethical issues associated with their use.

Dear friends,

Sorry that I haven't been myself lately. I'm not ignoring you or mad about something, it's just that I don't feel like myself. I really appreciate you and I won't always be this way. Please don't give up on me.

Sincerely, Your Friend

Major depressive disorder (MDD) or Depression is often described as having a loss of interest in daily activities and feeling hopeless. As discussed in our previous blog with Dr. Kakar, A Board Certified Psychiatrist Shares Surprising Facts About Depression, while those are common symptoms, depression varies by every individual. Depression varies by treatments, triggers, and the impact of MDD on a person’s life. In this blog, we’re unpacking those differences and sharing patients’ insights on clinical trials.